OBJECTIVE: To determine the prevalence of and risk factors for cervical dysplasia in HIV-positive women receiving care at the Jos University Teaching Hospital in Nigeria. METHODS: A total of 369 HIV-positive women had cervical cytology performed; HIV-1 RNA viral load and CD4 counts were measured. RESULTS: Of 369 participants, cervical dysplasia was present in 107 (29.0%) women. However, cervical cytology was abnormal in 252 (68.3%). Among those with abnormal cytology, 145 (57.5%) women had ASCUS, 56 (22.2%) had LSIL, and 51 (20.2%) had HSIL. Median CD4 lymphocyte count was lower in women with dysplasia compared with those without (142 vs 170 cells/mm(3); P=0.04), while median HIV RNA viral load was higher in women with dysplasia (101781 vs 77479 copies/mL; P=0.002). Low CD4 count (<200 cells/mm(3)) and evidence of HPV infection were significantly associated with cervical dysplasia. CONCLUSION: A high prevalence of cervical dysplasia was found among HIV-positive Nigerian women, which was associated with increased immune suppression.
OBJECTIVE: To determine the prevalence of and risk factors for cervical dysplasia in HIV-positive women receiving care at the Jos University Teaching Hospital in Nigeria. METHODS: A total of 369 HIV-positive women had cervical cytology performed; HIV-1 RNA viral load and CD4 counts were measured. RESULTS: Of 369 participants, cervical dysplasia was present in 107 (29.0%) women. However, cervical cytology was abnormal in 252 (68.3%). Among those with abnormal cytology, 145 (57.5%) women had ASCUS, 56 (22.2%) had LSIL, and 51 (20.2%) had HSIL. Median CD4 lymphocyte count was lower in women with dysplasia compared with those without (142 vs 170 cells/mm(3); P=0.04), while median HIV RNA viral load was higher in women with dysplasia (101781 vs 77479 copies/mL; P=0.002). Low CD4 count (<200 cells/mm(3)) and evidence of HPV infection were significantly associated with cervical dysplasia. CONCLUSION: A high prevalence of cervical dysplasia was found among HIV-positive Nigerian women, which was associated with increased immune suppression.
Authors: Michael H Chung; Kevin P McKenzie; Hugo De Vuyst; Barbra A Richardson; Farzana Rana; Ritesh Pamnani; Julia W Njoroge; Evans Nyongesa-Malava; Samah R Sakr; Grace C John-Stewart; Nelly R Mugo Journal: AIDS Date: 2013-11-28 Impact factor: 4.177
Authors: Jonah Musa; Chad Achenbach; Babafemi Taiwo; Baiba Berzins; Olugbenga Silas; Patrick H Daru; Oche Agbaji; Godwin Imade; Atiene S Sagay; John A Idoko; Phyllis J Kanki; Robert L Murphy Journal: Infect Agent Cancer Date: 2014-11-03 Impact factor: 2.965
Authors: Oliver C Ezechi; Chidinma V Gab-Okafor; Per Olof Ostergren; Karen Odberg Pettersson Journal: BMC Public Health Date: 2013-01-17 Impact factor: 3.295
Authors: Antoine Jaquet; Apollinaire Horo; Didier K Ekouevi; Badian Toure; Patrick A Coffie; Benjamin Effi; Severin Lenaud; Eugene Messou; Albert Minga; Annie J Sasco; François Dabis Journal: PLoS One Date: 2014-03-04 Impact factor: 3.240
Authors: Oliver Chukwujekwu Ezechi; Karen Odberg Pettersson; Clement Abu Okolo; Innocent Achaya O Ujah; Per Olof Ostergren Journal: PLoS One Date: 2014-05-08 Impact factor: 3.240